Funding for this research was provided by:
Division of Cancer Epidemiology and Genetics, National Cancer Institute (P30 CA016087, R01 CA164964, P50 CA225450)
National Institutes of Health (U01 CA250186, P20 CA252728)
Received: 29 April 2021
Accepted: 20 September 2021
First Online: 13 October 2021
: This study conforms to the Helsinki Declaration standards and was approved by the New York School of Medicine review board (IRB study number: 10362), and all participants provided informed consent.
: Not applicable.
: The authors declare that they have no competing interests.